The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis

Pathology and Oncology Research

Volumn 18, Issue 1, 2012, Pages 85-91

  Lakatos, Gábor ^a   Sipos, Ferenc ^a,b   Miheller, Pál ^a   Hritz, István ^a   Varga, Mária Zsófia ^a   Juhász, Márk ^a   Molnár, Béla ^b   Tulassay, Zsolt ^a,b   Herszényi, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Collagenous colitis; Immunohistochemistry; Inflammation; Lymphocytic colitis; Matrix metalloproteinase; Ulcerative colitis

Indexed keywords

GELATINASE B; PARAFFIN;

ADULT; ARTICLE; COLLAGENOUS COLITIS; COLON BIOPSY; COLON DIVERTICULOSIS; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EMBEDDING; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MUCOSA INFLAMMATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; UPREGULATION;

ADULT; AGED; ANALYSIS OF VARIANCE; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, ULCERATIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84855277084     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9420-9     Document Type: Article

References (39)

1. JB Kirsner 2001 Historical origins of current IBD concepts World J Gastroenterol 7 175 184 11819757 1:STN:280:DC%2BD383gs1GrtQ%3D%3D (Pubitemid 32377467)
2. T Kucharzik C Maaser A Lugering M Kagnoff L Mayer S Targan W Domschke 2006 Recent understanding of IBD pathogenesis: implications for future therapies Inflamm Bowel Dis 12 1068 1083 17075348 10.1097/01.mib.0000235827.21778.d5 (Pubitemid 44665477)
3. LA Liotta WG Stetler-Stevenson 1991 Tumor invasion and metastasis: an imbalance of positive and negative regulation Cancer Res 51 5054 5059
4. M Plebani L Herszényi R Cardin G Roveroni P Carraro M De Paoli M Rugge D Nitti R Naccarato F Farinati 1995 Cysteine and serine proteases in gastric cancer Cancer 76 367 375 8625115 1:STN:280:DyaK283itlSgug%3D%3D 10.1002/1097-0142(19950801)76:3<367::AID-CNCR2820760304>3.0.CO;2-B
5. L Herszényi M Plebani P Carraro M De Paoli R Roveroni R Cardin Zs Tulassay R Naccarato F Farinati 1999 The role of cysteine and serine proteases in colorectal cancer Cancer 86 1135 1142 10506696 10.1002/(SICI)1097- 0142(19991001)86:7<1135::AID-CNCR6>3.0.CO;2-2 (Pubitemid 29446994)
6. L Herszényi F Farinati R Cardin G István DL Molnár I Hritz M De Paoli M Plebani Z Tulassay 2008 Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer BMC Cancer 8 194 10.1186/1471-2407-8-194 18616803 10.1186/1471-2407-8-194
7. L Herszényi M Plebani P Carraro M De Paoli F Di Mario S Kusstatscher M Rugge R Cardin R Naccarato F Farinati 1997 Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer Am J Gastroenterol 92 843 847 9149198 (Pubitemid 27200803)
8. L Herszényi G István R Cardin M De Paoli M Plebani Z Tulassay F Farinati 2008 Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers Eur J Cancer Prev 17 438 445 18714186 10.1097/CEJ.0b013e328305a130
9. MD Baugh MJ Perry AP Hollander DR Davies SS Cross AJ Lobo CJ Taylor GS Evans 1999 Matrix metalloproteinase levels are elevated in inflammatory bowel disease Gastroenterology 117 814 822 10500063 1:CAS:528:DyaK1MXmvVWnurk%3D 10.1016/S0016-5085(99)70339-2 (Pubitemid 29468223)
10. B von Lampe B Barthel SE Coupland EO Riecken S Rosewicz 2000 Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease Gut 47 63 73 10.1136/gut.47.1.63 (Pubitemid 30430413)
11. G Monteleone R Caruso D Fina I Peluso V Gioia C Stolfi MC Fantini F Caprioli R Tersigni L Alessandroni TT MacDonald F Pallone 2006 Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 Gut 55 1774 1780 16682426 1:CAS:528:DC%2BD2sXkvFOjsw%3D%3D 10.1136/gut.2006. 093187 (Pubitemid 44893577)
12. A Ravi P Garg SV Sitaraman 2007 Matrix metalloproteinases in inflammatory bowel disease: Boon or a baine? Inflamm Bowel Dis 13 97 107 17206645 10.1002/ibd.20011 (Pubitemid 46080015)
13. L Herszényi I Hritz I Pregun F Sipos M Juhász B Molnár Z Tulassay 2007 Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in the esophageal carcinogenesis World J Gastroenterol 13 676 682 17278189
14. L Herszényi F Sipos O Galamb N Solymosi I Hritz P Miheller L Berczi B Molnár Z Tulassay 2008 Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon Pathol Oncol Res 14 1 31 37 18347934 10.1007/s12253-008-9004-5
15. AR Nelson B Fingleton ML Rothenberg LM Matrisian 2000 Matrix metalloproteinases: biologic activity and clinical implications J Clin Oncol 18 1135 1149 10694567 1:CAS:528:DC%2BD3cXitVCgsbg%3D (Pubitemid 30123793)
16. T Kirkegaard A Hansen E Bruun J Brynskov 2004 Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease Gut 53 701 709 15082589 1:CAS:528: DC%2BD2cXktlKitL4%3D 10.1136/gut.2003.017442 (Pubitemid 38561449)
17. CJ Bailey RM Hembry A Alexander MH Irving ME Grant CA Shuttleworth 1994 Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine J Clin Pathol 47 113 116 8132824 1:STN:280:DyaK2c7nvFGnug%3D%3D 10.1136/jcp.47.2.113 (Pubitemid 24095461)
18. A Stallmach CC Chan KW Ecker G Feifel H Herbst D Schuppan M Zeitz 2000 Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis Gut 47 415 422 10940281 1:CAS:528:DC%2BD3cXmsFOhtb0%3D 10.1136/gut.47.3.415
19. B Von Lampe B Barthel SE Coupland EO Riecken S Rosewicz 2000 Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease Gut 47 63 73 10.1136/gut.47.1.63 (Pubitemid 30430413)
20. OH Nielsen B Vainer OB de Muckadell 2004 Microscopic colitis: a missed diagnosis? Lancet 364 2055 2057 15582063 10.1016/S0140-6736(04)17518-1 (Pubitemid 39593082)
21. B Aqel M Bishop M Krishna J Cangemi 2003 Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature Dig Dis Sci 48 2323 2327 14714620 10.1023/B:DDAS.0000007870.18891.10 (Pubitemid 38021737)
22. F Sipos B Molnár T Zágoni L Berczi Z Tulassay 2005 Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel disease: ulcerative colitis shows specific p53- and EGFR expression alterations Dis Colon Rectum 48 775 786 15747078 10.1007/s10350-004-0831-5 (Pubitemid 40880726)
23. O Galamb F Sipos E Dinya S Spisak Z Tulassay B Molnar 2006 mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray World J Gastroenterol 12 6998 7006 17109495 1:CAS:528:DC%2BD28XhtlGhsrzN (Pubitemid 44834891)
24. C Medina MW Radomski 2006 Role of matrix metalloproteinases in intestinal inflammation J Pharmacol Exp Ther 318 3 933 938 16644899 1:CAS:528: DC%2BD28XovFygs7k%3D 10.1124/jpet.106.103465 (Pubitemid 44268297)
25. SL Pender SP Tickle AJ Docherty D Howie NC Wathen TT MacDonald 1997 A major role for matrix metalloproteinases in T cell injury in the gut J Immunol 158 4 1582 1590 9029093 1:CAS:528:DyaK2sXhtF2gtb4%3D (Pubitemid 127469511)
26. JN Gordon KM Pickard A Di Sabatino JD Prothero SL Pender PM Goggin TT MacDonald 2008 Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease Inflamm Bowel Dis 14 2 195 203 18022869 10.1002/ibd.20302 (Pubitemid 351288040)
27. P Garg M Vijay-Kumar L Wang AT Gewirtz D Merlin SV Sitaraman 2009 Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis Am J Physiol Gastrointest Liver Physiol 296 175 184 10.1152/ajpgi.90454.2008
28. N Nyhlin J Bohr S Eriksson C Tysk 2006 Systematic review: microscopic colitis Aliment Pharmacol Ther 23 11 1525 1534 16696800 1:STN:280: DC%2BD283mslensg%3D%3D 10.1111/j.1365-2036.2006.02913.x (Pubitemid 43727459)
29. Q Gao MJ Meijer FJ Kubben CF Sier L Kruidenier W van Duijn M van den Berg RA van Hogezand CB Lamers HW Verspaget 2005 Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases Dig Liver Dis 37 584 592 15869913 1:CAS:528:DC%2BD2MXhtVWltrjJ 10.1016/j.dld.2005.02.011 (Pubitemid 44356072)
30. MD Baugh MJ Perry AP Hollander DR Davies SS Cross AJ Lobo CJ Taylor GS Evans 1999 Matrix metalloproteinase levels are elevated in inflammatory bowel disease Gastroenterology 117 814 822 10500063 1:CAS:528:DyaK1MXmvVWnurk%3D 10.1016/S0016-5085(99)70339-2 (Pubitemid 29468223)
31. MA Manfredi D Zurakowski PA Rufo TR Walker VL Fox MA Moses 2008 Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease Inflamm Bowel Dis 14 1091 1096 18338781 10.1002/ibd.20419
32. FE Castaneda B Walia M Vijay-Kumar NR Patel S Roser VL Kolachala M Rojas L Wang G Oprea P Garg AT Gewirtz J Roman D Merlin SV Sitaraman 2005 Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP Gastroenterology 129 1991 2008 16344067 1:CAS:528:DC%2BD28Xks1Gmug%3D%3D 10.1053/j.gastro.2005.09.017 (Pubitemid 41772976)
33. M Martinesi C Treves AG Bonanomi M Milla S Bagnoli U Zuegel A Steinmeyer M Stio 2010 Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases Clin Immunol 136 51 60 20399147 1:CAS:528:DC%2BC3cXntVegs7o%3D 10.1016/j.clim.2010.03.004
34. MJ Meijer MA Mieremet-Ooms W van Duijn AM van der Zon R Hanemaaijer JH Verheijen RA van Hogezand CB Lamers HW Verspaget 2007 Effect of the tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease Inflamm Bowel Dis 13 200 210 17206679 10.1002/ibd.20051 (Pubitemid 46806229)
35. A Di Sabatino SL Pender CL Jackson JD Prothero JN Gordon L Picariello L Rovedatti G Docena G Monteleone DS Ramtpon F Tonelli GR Corazza TT MacDonald 2007 Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies Gastroenterology 133 137 149 17631138 10.1053/j.gastro.2007.04.069 (Pubitemid 47031137)
36. YD Wang PY Yan 2006 Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis World J Gastroenterol 12 6050 6053 17009408 1:CAS:528:DC%2BD28Xht1Wru7jI
37. K Kobayashi Y Arimura A Goto S Okahara T Endo Y Shinomura K Imai 2006 Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphat sodium J Pathol 209 376 383 16552705 1:CAS:528:DC%2BD28XnslOjt7w%3D 10.1002/path.1978 (Pubitemid 43997747)
38. S Miehlke P Heymer B Bethke E Bastlein E Meier HP Bartram G Wilhelms N Lehn G Dorta J DeLarive A Tromm E Bayerdörffer M Stolte 2002 Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial Gastroenterol 123 978 984 1:CAS:528:DC%2BD38Xotl2gtb4%3D 10.1053/gast.2002.36042
39. A Tromm T Griga HW Mollmann B May KM Muller A Fisseler-Eckhoff 1999 Budesonide for the treatment of collagenous colitis: first results of a pilot trial Am J Gastroenterol 94 1871 1875 10406251 1:CAS:528:DyaK1MXksFyksLk%3D 10.1111/j.1572-0241.1999.01222.x (Pubitemid 29315902)